Maven Securities LTD
Q1 2020 13F-HR Holdings
Net value change ($000)
-262,028
(-23.8%)
New positions
92
Sold out positions
117
Turnover %
202.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AAPL | 13,174 | 1004.9% |
| Allergan plc | 12,233 | NEW |
| TOI | 8,373 | NEW |
| RYAAY | 7,235 | 803.9% |
| MSFT | 7,157 | 1745.6% |
| AMZN | 6,201 | 1154.7% |
| SPY | 5,810 | NEW |
| META | 5,457 | 1991.6% |
| SHEL | 5,440 | NEW |
| DermTech, Inc. | 2,418 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| EEM | -27,439 | -100.0% |
| IMMUNOMEDICS INC | -16,446 | -100.0% |
| BHP | -15,607 | -100.0% |
| AGIO | -10,816 | -100.0% |
| REATA PHARMACEUTICALS INC | -10,256 | -100.0% |
| Zayo Group Holdings, Inc. | -8,049 | -100.0% |
| ARQULE INC | -6,954 | -100.0% |
| LIBERTY PROPERTY TRUST | -5,597 | -100.0% |
| PHR | -5,269 | -100.0% |
| bluebird bio, Inc. | -5,070 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
678,431
(80.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|